Get it on Google Play

BriaCell expands Phase 3 breast cancer study to 79 clinical sites

October 21, 2025 7:50 AM EDT Send to a Friend
BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) announced the addition of three major cancer centers to its ongoing Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login